Jubilant Cadista Pharmaceuticals, Inc. recalls clomiPRAMINE Hydrochloride Capsules USP, 50 mg, 30-count bottle, Rx Only, Manufactured by: Jubilant Cadista
Jubilant Cadista is recalling 50mg clomipramine hydrochloride capsules (Rx only) because of failed tablet specifications. This recall affects specific lots manufactured in Salisbury, MD. Consumers should contact the manufacturer for details.
Lower-risk recall
Failed Tablet/Capsule Specification
Contact the company & request your remedy
What happened, in plain English
Jubilant Cadista is recalling 50mg clomipramine hydrochloride capsules (Rx only) due to failed tablet specifications. This means the capsules may not meet quality standards, though the recall does not indicate immediate safety risks. Read more at govinfonow.com/recall/36688-jubilant-cadista-recalls-50mg-clomipramine-capsules-due-to-failed-tablet.
Source Summary by GovInfoNow · govinfonow.com/recall/36688-jubilant-cadista-recalls-50mg-clomipramine-capsules-due-to-failed-tablet · Updated October 4, 2026 · FDA enforcement record: FDA #D-0104-2021
Cite this page
“Jubilant Cadista recalls 50mg clomipramine capsules due to failed tablet specification.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36688-jubilant-cadista-recalls-50mg-clomipramine-capsules-due-to-failed-tablet. Based on FDA recall #D-0104-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0104-2021%22&limit=1).
Why it’s dangerous
The capsules failed tablet specifications, meaning they may not meet quality standards. This could affect the medication's effectiveness or safety, but the recall does not indicate immediate risks like injury or death.
Who’s affected
Prescription patients who received the specific lot (20P0141) of 50mg clomipramine hydrochloride capsules from Jubilant Cadista. Those with the NDC 59746-711-30 and expiration date 02/2022 are most at risk.
How to tell if you have this one
Check for the product name 'clomipramine hydrochloride capsules USP 50 mg', NDC 59746-711-30, lot number 20P0141, and expiration date 02/2022. This product was manufactured by Jubilant Cadista Pharmaceuticals in Salisbury, MD.
- Brand
Jubilant Cadista- Category
Drug
What to do — step by step
Contact Manufacturer
Reach out to Jubilant Cadista Pharmaceuticals for specific instructions on handling the recalled product.
Questions people ask
Is this product safe to use?
The recall indicates failed tablet specifications, but the official notice does not state that the product is unsafe. Consumers should contact the manufacturer for details.
What should I do if I have this product?
The recall does not specify a remedy, so contact Jubilant Cadista Pharmaceuticals for instructions.
How can I check if I have the recalled product?
Look for the NDC 59746-711-30, lot number 20P0141, and expiration date 02/2022 on the product label.
Contact Jubilant Cadista
We’ve drafted a message you can send Jubilant Cadista to request your refund or repair — edit it as you like.
Subject: Recall D-0104-2021 — Jubilant Cadista Jubilant Cadista Hello, I own a Jubilant Cadista that is covered by recall D-0104-2021 from Jubilant Cadista. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0104-2021 (November 6, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0104-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.